Would be interested to see who MSB's advisors are on this one.
The Type A meeting will clearly involve higher ups at the FDA (who presumably had a reasonable degree of awareness of the issues involved in CRL-ing the application). But what pressure and influence can be brought to bear at other channels, parallel to and yes, even above the FDA?
I think it's safe to assume that MSB will be putting on the full-court press here, and that there will be an effort to lobby at the highest levels within and outside the FDA. Throughout my legal career, I have handled a number of cases that, at the local/operational level, seemed hopeless, but via lobbying (including via national level offices, and on a few occasions, international pressure through the embassies of my clients), suddenly turned around and ended in victory.
There are a ton of levers that can be pulled here.
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-214
-
- There are more pages in this discussion • 804 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 75212 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.185 |
1 | 20000 | 1.175 |
1 | 5664 | 1.170 |
1 | 17568 | 1.160 |
3 | 56695 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 59712 | 2 |
1.195 | 36255 | 5 |
1.200 | 404381 | 31 |
1.205 | 3000 | 1 |
1.210 | 162475 | 7 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |